NDC Code(s) : 0409-2012-03, 0409-2012-32
Packager : Hospira, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : CIII
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Buprenorphine HydrochlorideBuprenorphine Hydrochloride INJECTION, SOLUTION | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
LABELER - Hospira, Inc.(141588017) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Hospira, Inc. | 030606222 | ANALYSIS(0409-2012), MANUFACTURE(0409-2012) |
PRINCIPAL DISPLAY PANEL
NDC 0409-2012-03
1 mL Single-dose Carpuject™
Sterile Cartridge Unit with Luer Lock
Buprenorphine
Hydrochloride Injection
CIII
Rx only
0.3 mg base/mL
For Intramuscular or Intravenous Use
PROTECT FROM LIGHT
PAA146018
Hospira
LOT #####AA
EXP DMMMYYYY
PRINCIPAL DISPLAY PANEL
NDC 0409-2012-32
Contains 10 of NDC 0409-2012-03
Rx only
1 mL Single-dose
10 Carpuject™
Sterile Cartridge Units
with Luer Lock
Needle not included
SLIM-PAK™
Tamper Detection Package
Buprenorphine
Hydrochloride
Injection
CIII
0.3 mg base/mL
For Intramuscular or
Intravenous Use
Carpuject Cartridges are
to be used ONLY with
Carpuject Holders.
Hospira